The pharmaceutical giant Bayer announced Monday that it would end non-US sales of Essure, a sterilisation implant that in news reports has been linked to major side effects.
"This decision is being taken for commercial reasons," the German group said.
The withdrawal extended a decision taken in May to halt sales of the device in most countries where it wasRead more
The pharmaceutical giant Bayer announced Monday that it would end non-US sales of Essure, a sterilisation implant that has been linked to major side effects.
"This decision is being taken for commercial reasons," the German group said, adding that the withdrawal extended a decision taken in May to halt sales of the device in most countries.
Essure, a non-hormonal coilRead more
German chemicals and pharmaceuticals giant Bayer on Wednesday said it had slightly increased its forecast for the whole year, driven by strong sales of prescription drugs.
Results released by the firm showed it had increased profits by 18.8 percent to 1.2 billion euros ($1.3 billion) between July and September compared with the same period the previous year, on sales ofRead more
German chemicals firm Bayer said on Monday it would not introduce genetically modified crops in Europe after its gigantic takeover of US seed and pesticide producer Monsanto.
"We aren't taking over Monsanto to establish GM plants in Europe," chief executive Werner Baumann told the Sueddeutsche Zeitung newspaper.
"Some people think it might be easier for us than for Monsanto, givenRead more
German pharmaceuticals and chemicals group Bayer AG said Tuesday it is targeting increased sales and earnings growth over the next few years at its drug and crop-science businesses, just days after announcing a planned $66 billion takeover of US seed company Monsanto Co. "We are optimistic about Bayer's medium-term development and have therefore set ambitious aspirations," said Chief Executive WernerRead more
German chemicals giant Bayer said Tuesday it had increased its earnings and profits forecasts after signing a deal to take over US seeds and pesticides maker Monsanto.
"We are optimistic for the medium-term development of Bayer and have set ourselves correspondingly ambitious targets," chief executive Werner Baumann said in a statement.
In the crop science division that will integrate Monsanto,Read more
The German pharmaceutical and chemicals group Bayer said it would sweeten its offer for US rival Monsanto.
In a statement released late Monday, Bayer said it would raise its offer for the US seed giant to $127.50 per share from $125. That would bring the deal's total value to almost $66 billion including debt.
Monsanto confirmed Bayer's improved bid forRead more
German chemicals giant Bayer may launch a hostile takeover bid for US seed and pesticide maker Monsanto if its latest friendly offer falls through, business daily Handelsblatt reported on Tuesday.
Monsanto has already rejected two offers from the German firm, calling an increased $125-per-share bid in July "financially inadequate" while keeping the door open to further discussions.
"Bayer is preparedRead more
Germany's chemicals giants showed sharply differing results on Wednesday, with Bayer enjoying strong growth on pharmaceuticals while oil blackened BASF's outlook.
Chemicals and pharmaceuticals powerhouse Bayer upped its growth forecasts for the year after a strong second quarter saw profits surge by 19 percent.
While revenues fell 1.4 percent to 11.8 billion euros ($13 billion), profits hit 1.4 billion eurosRead more
The German industrial giant Bayer raised its all-cash takeover bid for Monsanto on Thursday, turning up the heat in its pursuit of the American agricultural company.
In a news release, Bayer said that it had increased its offer to $125 a share from $122 a share.
Bayer’s new offer — still the largest takeover bid by a German company —Read more